Excedrin
This article was originally published in The Tan Sheet
Executive Summary
Bristol-Myers Squibb reassigns advertising for three of its Excedrin products from DDB Needham, New York, which reportedly dropped the brands. Excedrin and Aspirin-Free Excedrin went to Bozell Worldwide while Excedrin PM was awarded to J. Walter Thompson, which currently handles another BMS pain reliever, Nuprin. The firm reportedly is considering increased ad spending for one of the Excedrin products this year.